JPWO2020113237A5 - - Google Patents
Download PDFInfo
- Publication number
- JPWO2020113237A5 JPWO2020113237A5 JP2021530882A JP2021530882A JPWO2020113237A5 JP WO2020113237 A5 JPWO2020113237 A5 JP WO2020113237A5 JP 2021530882 A JP2021530882 A JP 2021530882A JP 2021530882 A JP2021530882 A JP 2021530882A JP WO2020113237 A5 JPWO2020113237 A5 JP WO2020113237A5
- Authority
- JP
- Japan
- Prior art keywords
- machine learning
- group
- data
- computers
- folfox
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 238000010801 machine learning Methods 0.000 claims description 151
- 238000011282 treatment Methods 0.000 claims description 98
- 238000000034 method Methods 0.000 claims description 91
- YXTKHLHCVFUPPT-YYFJYKOTSA-N (2s)-2-[[4-[(2-amino-5-formyl-4-oxo-1,6,7,8-tetrahydropteridin-6-yl)methylamino]benzoyl]amino]pentanedioic acid;(1r,2r)-1,2-dimethanidylcyclohexane;5-fluoro-1h-pyrimidine-2,4-dione;oxalic acid;platinum(2+) Chemical compound [Pt+2].OC(=O)C(O)=O.[CH2-][C@@H]1CCCC[C@H]1[CH2-].FC1=CNC(=O)NC1=O.C1NC=2NC(N)=NC(=O)C=2N(C=O)C1CNC1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 YXTKHLHCVFUPPT-YYFJYKOTSA-N 0.000 claims description 71
- 230000008901 benefit Effects 0.000 claims description 58
- 238000012545 processing Methods 0.000 claims description 45
- 102100032481 B-cell CLL/lymphoma 9 protein Human genes 0.000 claims description 36
- 101000798495 Homo sapiens B-cell CLL/lymphoma 9 protein Proteins 0.000 claims description 36
- 101000610107 Homo sapiens Pre-B-cell leukemia transcription factor 1 Proteins 0.000 claims description 36
- 102100040171 Pre-B-cell leukemia transcription factor 1 Human genes 0.000 claims description 36
- 102100032610 Guanine nucleotide-binding protein G(s) subunit alpha isoforms XLas Human genes 0.000 claims description 35
- 101001014590 Homo sapiens Guanine nucleotide-binding protein G(s) subunit alpha isoforms XLas Proteins 0.000 claims description 35
- 101001014594 Homo sapiens Guanine nucleotide-binding protein G(s) subunit alpha isoforms short Proteins 0.000 claims description 35
- 101001014610 Homo sapiens Neuroendocrine secretory protein 55 Proteins 0.000 claims description 35
- 101000797903 Homo sapiens Protein ALEX Proteins 0.000 claims description 35
- 108090000623 proteins and genes Proteins 0.000 claims description 35
- 101000728236 Homo sapiens Polycomb group protein ASXL1 Proteins 0.000 claims description 34
- 102100029799 Polycomb group protein ASXL1 Human genes 0.000 claims description 34
- 206010028980 Neoplasm Diseases 0.000 claims description 33
- 102100025007 14-3-3 protein epsilon Human genes 0.000 claims description 27
- 101000760079 Homo sapiens 14-3-3 protein epsilon Proteins 0.000 claims description 27
- 101001069727 Homo sapiens Paired mesoderm homeobox protein 1 Proteins 0.000 claims description 27
- 102100027004 Inhibin beta A chain Human genes 0.000 claims description 27
- 102100033786 Paired mesoderm homeobox protein 1 Human genes 0.000 claims description 27
- 108010019691 inhibin beta A subunit Proteins 0.000 claims description 27
- 102000004000 Aurora Kinase A Human genes 0.000 claims description 26
- 108090000461 Aurora Kinase A Proteins 0.000 claims description 26
- 230000008569 process Effects 0.000 claims description 25
- 102100026548 Caspase-8 Human genes 0.000 claims description 24
- 101000983528 Homo sapiens Caspase-8 Proteins 0.000 claims description 24
- 101000981546 Homo sapiens LHFPL tetraspan subfamily member 6 protein Proteins 0.000 claims description 24
- 102100024116 LHFPL tetraspan subfamily member 6 protein Human genes 0.000 claims description 24
- 238000002560 therapeutic procedure Methods 0.000 claims description 22
- 238000013145 classification model Methods 0.000 claims description 21
- 102100029375 Crk-like protein Human genes 0.000 claims description 20
- 101000919315 Homo sapiens Crk-like protein Proteins 0.000 claims description 20
- 101001013158 Homo sapiens Myeloid leukemia factor 1 Proteins 0.000 claims description 20
- 102100029691 Myeloid leukemia factor 1 Human genes 0.000 claims description 20
- 239000012472 biological sample Substances 0.000 claims description 20
- 102100038885 Histone acetyltransferase p300 Human genes 0.000 claims description 18
- 101000882390 Homo sapiens Histone acetyltransferase p300 Proteins 0.000 claims description 18
- 206010009944 Colon cancer Diseases 0.000 claims description 16
- 108010083123 CDX2 Transcription Factor Proteins 0.000 claims description 15
- 208000001333 Colorectal Neoplasms Diseases 0.000 claims description 15
- 102100031513 Fc receptor-like protein 4 Human genes 0.000 claims description 15
- 102100031671 Homeobox protein CDX-2 Human genes 0.000 claims description 15
- 101000846909 Homo sapiens Fc receptor-like protein 4 Proteins 0.000 claims description 15
- 239000012530 fluid Substances 0.000 claims description 15
- 102100031456 Centriolin Human genes 0.000 claims description 14
- 101000941711 Homo sapiens Centriolin Proteins 0.000 claims description 14
- 101001005667 Homo sapiens Mastermind-like protein 2 Proteins 0.000 claims description 14
- 101001030211 Homo sapiens Myc proto-oncogene protein Proteins 0.000 claims description 14
- 101000808799 Homo sapiens Splicing factor U2AF 35 kDa subunit Proteins 0.000 claims description 14
- 102100025130 Mastermind-like protein 2 Human genes 0.000 claims description 14
- 102100038895 Myc proto-oncogene protein Human genes 0.000 claims description 14
- 102100038501 Splicing factor U2AF 35 kDa subunit Human genes 0.000 claims description 14
- 210000004027 cell Anatomy 0.000 claims description 14
- VVIAGPKUTFNRDU-UHFFFAOYSA-N 6S-folinic acid Natural products C1NC=2NC(N)=NC(=O)C=2N(C=O)C1CNC1=CC=C(C(=O)NC(CCC(O)=O)C(O)=O)C=C1 VVIAGPKUTFNRDU-UHFFFAOYSA-N 0.000 claims description 13
- 108700003785 Baculoviral IAP Repeat-Containing 3 Proteins 0.000 claims description 13
- 102100021662 Baculoviral IAP repeat-containing protein 3 Human genes 0.000 claims description 13
- 101150104237 Birc3 gene Proteins 0.000 claims description 13
- GHASVSINZRGABV-UHFFFAOYSA-N Fluorouracil Chemical compound FC1=CNC(=O)NC1=O GHASVSINZRGABV-UHFFFAOYSA-N 0.000 claims description 13
- 102100030308 Homeobox protein Hox-A11 Human genes 0.000 claims description 13
- 101001083158 Homo sapiens Homeobox protein Hox-A11 Proteins 0.000 claims description 13
- 101100379220 Saccharomyces cerevisiae (strain ATCC 204508 / S288c) API2 gene Proteins 0.000 claims description 13
- 229960002949 fluorouracil Drugs 0.000 claims description 13
- VVIAGPKUTFNRDU-ABLWVSNPSA-N folinic acid Chemical compound C1NC=2NC(N)=NC(=O)C=2N(C=O)C1CNC1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 VVIAGPKUTFNRDU-ABLWVSNPSA-N 0.000 claims description 13
- 235000008191 folinic acid Nutrition 0.000 claims description 13
- 239000011672 folinic acid Substances 0.000 claims description 13
- 229960001691 leucovorin Drugs 0.000 claims description 13
- 238000007637 random forest analysis Methods 0.000 claims description 13
- 101000581507 Homo sapiens Methyl-CpG-binding domain protein 1 Proteins 0.000 claims description 12
- 101000576323 Homo sapiens Motor neuron and pancreas homeobox protein 1 Proteins 0.000 claims description 12
- 101001134861 Homo sapiens Pericentriolar material 1 protein Proteins 0.000 claims description 12
- 101000591128 Homo sapiens RNA-binding protein Musashi homolog 2 Proteins 0.000 claims description 12
- 101000804798 Homo sapiens Werner syndrome ATP-dependent helicase Proteins 0.000 claims description 12
- 102100027383 Methyl-CpG-binding domain protein 1 Human genes 0.000 claims description 12
- 102100025170 Motor neuron and pancreas homeobox protein 1 Human genes 0.000 claims description 12
- 102100034027 RNA-binding protein Musashi homolog 2 Human genes 0.000 claims description 12
- -1 TERT Proteins 0.000 claims description 12
- 102100035336 Werner syndrome ATP-dependent helicase Human genes 0.000 claims description 12
- 102100038776 ADP-ribosylation factor-related protein 1 Human genes 0.000 claims description 11
- 102100034580 AT-rich interactive domain-containing protein 1A Human genes 0.000 claims description 11
- 102100022089 Acyl-[acyl-carrier-protein] hydrolase Human genes 0.000 claims description 11
- 101000964894 Bos taurus 14-3-3 protein zeta/delta Proteins 0.000 claims description 11
- 102100033642 Bromodomain-containing protein 3 Human genes 0.000 claims description 11
- 102100026359 Cyclic AMP-responsive element-binding protein 1 Human genes 0.000 claims description 11
- 102100028202 Cytochrome c oxidase subunit 6C Human genes 0.000 claims description 11
- 102100024607 DNA topoisomerase 1 Human genes 0.000 claims description 11
- 102100023274 Dual specificity mitogen-activated protein kinase kinase 4 Human genes 0.000 claims description 11
- 102100020903 Ezrin Human genes 0.000 claims description 11
- 102100034553 Fanconi anemia group J protein Human genes 0.000 claims description 11
- 102100037858 G1/S-specific cyclin-E1 Human genes 0.000 claims description 11
- 102100031493 Growth arrest-specific protein 7 Human genes 0.000 claims description 11
- 102100029235 Histone-lysine N-methyltransferase NSD3 Human genes 0.000 claims description 11
- 101000809413 Homo sapiens ADP-ribosylation factor-related protein 1 Proteins 0.000 claims description 11
- 101000924266 Homo sapiens AT-rich interactive domain-containing protein 1A Proteins 0.000 claims description 11
- 101000824278 Homo sapiens Acyl-[acyl-carrier-protein] hydrolase Proteins 0.000 claims description 11
- 101000871851 Homo sapiens Bromodomain-containing protein 3 Proteins 0.000 claims description 11
- 101000855516 Homo sapiens Cyclic AMP-responsive element-binding protein 1 Proteins 0.000 claims description 11
- 101000861049 Homo sapiens Cytochrome c oxidase subunit 6C Proteins 0.000 claims description 11
- 101000830681 Homo sapiens DNA topoisomerase 1 Proteins 0.000 claims description 11
- 101001115395 Homo sapiens Dual specificity mitogen-activated protein kinase kinase 4 Proteins 0.000 claims description 11
- 101000848171 Homo sapiens Fanconi anemia group J protein Proteins 0.000 claims description 11
- 101000738568 Homo sapiens G1/S-specific cyclin-E1 Proteins 0.000 claims description 11
- 101000923044 Homo sapiens Growth arrest-specific protein 7 Proteins 0.000 claims description 11
- 101000634046 Homo sapiens Histone-lysine N-methyltransferase NSD3 Proteins 0.000 claims description 11
- 101000961071 Homo sapiens NF-kappa-B inhibitor alpha Proteins 0.000 claims description 11
- 101000973211 Homo sapiens Nuclear factor 1 B-type Proteins 0.000 claims description 11
- 101000601661 Homo sapiens Paired box protein Pax-7 Proteins 0.000 claims description 11
- 101000579484 Homo sapiens Period circadian protein homolog 1 Proteins 0.000 claims description 11
- 101001126582 Homo sapiens Post-GPI attachment to proteins factor 3 Proteins 0.000 claims description 11
- 101000798015 Homo sapiens RAC-beta serine/threonine-protein kinase Proteins 0.000 claims description 11
- 101100078258 Homo sapiens RUNX1T1 gene Proteins 0.000 claims description 11
- 101000932478 Homo sapiens Receptor-type tyrosine-protein kinase FLT3 Proteins 0.000 claims description 11
- 101000687474 Homo sapiens Rhombotin-1 Proteins 0.000 claims description 11
- 101000631899 Homo sapiens Ribosome maturation protein SBDS Proteins 0.000 claims description 11
- 101000654740 Homo sapiens Septin-5 Proteins 0.000 claims description 11
- 101000740519 Homo sapiens Syndecan-4 Proteins 0.000 claims description 11
- 101000655119 Homo sapiens T-cell leukemia homeobox protein 3 Proteins 0.000 claims description 11
- 101000837401 Homo sapiens T-cell leukemia/lymphoma protein 1A Proteins 0.000 claims description 11
- 101000702545 Homo sapiens Transcription activator BRG1 Proteins 0.000 claims description 11
- 101000813738 Homo sapiens Transcription factor ETV6 Proteins 0.000 claims description 11
- 101000664703 Homo sapiens Transcription factor SOX-10 Proteins 0.000 claims description 11
- 101001051166 Homo sapiens Transcriptional activator MN1 Proteins 0.000 claims description 11
- 101000611023 Homo sapiens Tumor necrosis factor receptor superfamily member 6 Proteins 0.000 claims description 11
- 101000851018 Homo sapiens Vascular endothelial growth factor receptor 1 Proteins 0.000 claims description 11
- 101000650162 Homo sapiens WW domain-containing transcription regulator protein 1 Proteins 0.000 claims description 11
- 101000782132 Homo sapiens Zinc finger protein 217 Proteins 0.000 claims description 11
- 102000000588 Interleukin-2 Human genes 0.000 claims description 11
- 108010002350 Interleukin-2 Proteins 0.000 claims description 11
- 102000004034 Kelch-Like ECH-Associated Protein 1 Human genes 0.000 claims description 11
- 108090000484 Kelch-Like ECH-Associated Protein 1 Proteins 0.000 claims description 11
- 102100039337 NF-kappa-B inhibitor alpha Human genes 0.000 claims description 11
- 102100022165 Nuclear factor 1 B-type Human genes 0.000 claims description 11
- 102100037503 Paired box protein Pax-7 Human genes 0.000 claims description 11
- 102100028293 Period circadian protein homolog 1 Human genes 0.000 claims description 11
- 102100040990 Platelet-derived growth factor subunit B Human genes 0.000 claims description 11
- 102100024952 Protein CBFA2T1 Human genes 0.000 claims description 11
- 108010019674 Proto-Oncogene Proteins c-sis Proteins 0.000 claims description 11
- 102100032315 RAC-beta serine/threonine-protein kinase Human genes 0.000 claims description 11
- 108090000740 RNA-binding protein EWS Proteins 0.000 claims description 11
- 102000004229 RNA-binding protein EWS Human genes 0.000 claims description 11
- 108700040655 RUNX1 Translocation Partner 1 Proteins 0.000 claims description 11
- 102100020718 Receptor-type tyrosine-protein kinase FLT3 Human genes 0.000 claims description 11
- 102100024869 Rhombotin-1 Human genes 0.000 claims description 11
- 102100028750 Ribosome maturation protein SBDS Human genes 0.000 claims description 11
- 102100032744 Septin-5 Human genes 0.000 claims description 11
- 102100037220 Syndecan-4 Human genes 0.000 claims description 11
- 102100032568 T-cell leukemia homeobox protein 3 Human genes 0.000 claims description 11
- 102100028676 T-cell leukemia/lymphoma protein 1A Human genes 0.000 claims description 11
- 102100031027 Transcription activator BRG1 Human genes 0.000 claims description 11
- 102100039580 Transcription factor ETV6 Human genes 0.000 claims description 11
- 102100038808 Transcription factor SOX-10 Human genes 0.000 claims description 11
- 102100024592 Transcriptional activator MN1 Human genes 0.000 claims description 11
- 102100033178 Vascular endothelial growth factor receptor 1 Human genes 0.000 claims description 11
- 102100027548 WW domain-containing transcription regulator protein 1 Human genes 0.000 claims description 11
- 101100100541 Zea mays BX1 gene Proteins 0.000 claims description 11
- 102100036595 Zinc finger protein 217 Human genes 0.000 claims description 11
- 102000004169 proteins and genes Human genes 0.000 claims description 11
- 210000001519 tissue Anatomy 0.000 claims description 10
- 102100022716 Atypical chemokine receptor 3 Human genes 0.000 claims description 9
- 101000678890 Homo sapiens Atypical chemokine receptor 3 Proteins 0.000 claims description 9
- 101000798007 Homo sapiens RAC-gamma serine/threonine-protein kinase Proteins 0.000 claims description 9
- 101000796673 Homo sapiens Transformation/transcription domain-associated protein Proteins 0.000 claims description 9
- 102100032314 RAC-gamma serine/threonine-protein kinase Human genes 0.000 claims description 9
- 102100032762 Transformation/transcription domain-associated protein Human genes 0.000 claims description 9
- 102000039446 nucleic acids Human genes 0.000 claims description 8
- 108020004707 nucleic acids Proteins 0.000 claims description 8
- 150000007523 nucleic acids Chemical class 0.000 claims description 8
- DWAFYCQODLXJNR-BNTLRKBRSA-L oxaliplatin Chemical compound O1C(=O)C(=O)O[Pt]11N[C@@H]2CCCC[C@H]2N1 DWAFYCQODLXJNR-BNTLRKBRSA-L 0.000 claims description 8
- 229960001756 oxaliplatin Drugs 0.000 claims description 8
- 238000012163 sequencing technique Methods 0.000 claims description 8
- 238000003860 storage Methods 0.000 claims description 8
- UWKQSNNFCGGAFS-XIFFEERXSA-N irinotecan Chemical compound C1=C2C(CC)=C3CN(C(C4=C([C@@](C(=O)OC4)(O)CC)C=4)=O)C=4C3=NC2=CC=C1OC(=O)N(CC1)CCC1N1CCCCC1 UWKQSNNFCGGAFS-XIFFEERXSA-N 0.000 claims description 7
- 229960004768 irinotecan Drugs 0.000 claims description 7
- 239000000523 sample Substances 0.000 claims description 7
- 210000001124 body fluid Anatomy 0.000 claims description 6
- 101000854648 Homo sapiens Ezrin Proteins 0.000 claims description 5
- 230000009471 action Effects 0.000 claims description 5
- 230000003211 malignant effect Effects 0.000 claims description 5
- WSFSSNUMVMOOMR-UHFFFAOYSA-N Formaldehyde Chemical compound O=C WSFSSNUMVMOOMR-UHFFFAOYSA-N 0.000 claims description 4
- 208000015634 Rectal Neoplasms Diseases 0.000 claims description 4
- 210000003567 ascitic fluid Anatomy 0.000 claims description 4
- 210000001175 cerebrospinal fluid Anatomy 0.000 claims description 4
- 210000003608 fece Anatomy 0.000 claims description 4
- 210000004910 pleural fluid Anatomy 0.000 claims description 4
- 206010038038 rectal cancer Diseases 0.000 claims description 4
- 201000001275 rectum cancer Diseases 0.000 claims description 4
- 239000000284 extract Substances 0.000 claims description 3
- 206010003445 Ascites Diseases 0.000 claims description 2
- 108091005461 Nucleic proteins Proteins 0.000 claims description 2
- 208000005228 Pericardial Effusion Diseases 0.000 claims description 2
- 206010036790 Productive cough Diseases 0.000 claims description 2
- 210000004381 amniotic fluid Anatomy 0.000 claims description 2
- 210000001742 aqueous humor Anatomy 0.000 claims description 2
- 210000000941 bile Anatomy 0.000 claims description 2
- 210000004952 blastocoel Anatomy 0.000 claims description 2
- 210000001185 bone marrow Anatomy 0.000 claims description 2
- 210000002533 bulbourethral gland Anatomy 0.000 claims description 2
- 210000002939 cerumen Anatomy 0.000 claims description 2
- 210000003756 cervix mucus Anatomy 0.000 claims description 2
- 210000001268 chyle Anatomy 0.000 claims description 2
- 210000004913 chyme Anatomy 0.000 claims description 2
- 210000003722 extracellular fluid Anatomy 0.000 claims description 2
- 210000004700 fetal blood Anatomy 0.000 claims description 2
- 210000004251 human milk Anatomy 0.000 claims description 2
- 235000020256 human milk Nutrition 0.000 claims description 2
- 230000001926 lymphatic effect Effects 0.000 claims description 2
- 230000002175 menstrual effect Effects 0.000 claims description 2
- 210000003097 mucus Anatomy 0.000 claims description 2
- 238000013188 needle biopsy Methods 0.000 claims description 2
- 210000001819 pancreatic juice Anatomy 0.000 claims description 2
- 210000004912 pericardial fluid Anatomy 0.000 claims description 2
- 210000005259 peripheral blood Anatomy 0.000 claims description 2
- 239000011886 peripheral blood Substances 0.000 claims description 2
- 210000002381 plasma Anatomy 0.000 claims description 2
- 210000004908 prostatic fluid Anatomy 0.000 claims description 2
- 210000004915 pus Anatomy 0.000 claims description 2
- 210000003296 saliva Anatomy 0.000 claims description 2
- 210000002374 sebum Anatomy 0.000 claims description 2
- 230000028327 secretion Effects 0.000 claims description 2
- 210000000582 semen Anatomy 0.000 claims description 2
- 210000002966 serum Anatomy 0.000 claims description 2
- 210000003802 sputum Anatomy 0.000 claims description 2
- 208000024794 sputum Diseases 0.000 claims description 2
- 210000004243 sweat Anatomy 0.000 claims description 2
- 210000001179 synovial fluid Anatomy 0.000 claims description 2
- 210000001138 tear Anatomy 0.000 claims description 2
- 210000002700 urine Anatomy 0.000 claims description 2
- 210000004916 vomit Anatomy 0.000 claims description 2
- 230000008673 vomiting Effects 0.000 claims description 2
- 239000003124 biologic agent Substances 0.000 claims 3
- 210000001072 colon Anatomy 0.000 claims 3
- JYEFSHLLTQIXIO-SMNQTINBSA-N folfiri regimen Chemical compound FC1=CNC(=O)NC1=O.C1NC=2NC(N)=NC(=O)C=2N(C=O)C1CNC1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1.C1=C2C(CC)=C3CN(C(C4=C([C@@](C(=O)OC4)(O)CC)C=4)=O)C=4C3=NC2=CC=C1OC(=O)N(CC1)CCC1N1CCCCC1 JYEFSHLLTQIXIO-SMNQTINBSA-N 0.000 claims 3
- 206010052358 Colorectal cancer metastatic Diseases 0.000 claims 2
- 229960000397 bevacizumab Drugs 0.000 claims 2
- 229960005395 cetuximab Drugs 0.000 claims 2
- 229960000074 biopharmaceutical Drugs 0.000 claims 1
- 239000010839 body fluid Substances 0.000 claims 1
- 239000003795 chemical substances by application Substances 0.000 claims 1
- 238000007482 whole exome sequencing Methods 0.000 claims 1
- 239000000090 biomarker Substances 0.000 description 32
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 25
- 201000011510 cancer Diseases 0.000 description 21
- 201000010099 disease Diseases 0.000 description 13
- 208000035475 disorder Diseases 0.000 description 12
- 238000003556 assay Methods 0.000 description 11
- 238000012549 training Methods 0.000 description 8
- 108010011536 PTEN Phosphohydrolase Proteins 0.000 description 7
- 102000014160 PTEN Phosphohydrolase Human genes 0.000 description 7
- 238000003364 immunohistochemistry Methods 0.000 description 6
- 102100037799 DNA-binding protein Ikaros Human genes 0.000 description 4
- 101000599038 Homo sapiens DNA-binding protein Ikaros Proteins 0.000 description 4
- 210000003169 central nervous system Anatomy 0.000 description 4
- 201000009030 Carcinoma Diseases 0.000 description 3
- 108020004414 DNA Proteins 0.000 description 3
- 102000053602 DNA Human genes 0.000 description 3
- 206010073059 Malignant neoplasm of unknown primary site Diseases 0.000 description 3
- 206010035226 Plasma cell myeloma Diseases 0.000 description 3
- 230000002496 gastric effect Effects 0.000 description 3
- 208000032839 leukemia Diseases 0.000 description 3
- 238000007481 next generation sequencing Methods 0.000 description 3
- 208000031261 Acute myeloid leukaemia Diseases 0.000 description 2
- 201000008271 Atypical teratoid rhabdoid tumor Diseases 0.000 description 2
- 206010004593 Bile duct cancer Diseases 0.000 description 2
- 208000003174 Brain Neoplasms Diseases 0.000 description 2
- 206010006143 Brain stem glioma Diseases 0.000 description 2
- 206010006187 Breast cancer Diseases 0.000 description 2
- 208000026310 Breast neoplasm Diseases 0.000 description 2
- 208000037138 Central nervous system embryonal tumor Diseases 0.000 description 2
- 208000008839 Kidney Neoplasms Diseases 0.000 description 2
- 206010025323 Lymphomas Diseases 0.000 description 2
- 208000034578 Multiple myelomas Diseases 0.000 description 2
- 201000007224 Myeloproliferative neoplasm Diseases 0.000 description 2
- 208000007571 Ovarian Epithelial Carcinoma Diseases 0.000 description 2
- 206010033128 Ovarian cancer Diseases 0.000 description 2
- 208000007641 Pinealoma Diseases 0.000 description 2
- 208000033014 Plasma cell tumor Diseases 0.000 description 2
- 208000007452 Plasmacytoma Diseases 0.000 description 2
- 206010038389 Renal cancer Diseases 0.000 description 2
- 208000024770 Thyroid neoplasm Diseases 0.000 description 2
- 230000003321 amplification Effects 0.000 description 2
- 230000006399 behavior Effects 0.000 description 2
- 238000004422 calculation algorithm Methods 0.000 description 2
- 238000013500 data storage Methods 0.000 description 2
- 201000011243 gastrointestinal stromal tumor Diseases 0.000 description 2
- 206010073071 hepatocellular carcinoma Diseases 0.000 description 2
- 231100000844 hepatocellular carcinoma Toxicity 0.000 description 2
- 201000010982 kidney cancer Diseases 0.000 description 2
- 230000036210 malignancy Effects 0.000 description 2
- 201000005962 mycosis fungoides Diseases 0.000 description 2
- 208000002154 non-small cell lung carcinoma Diseases 0.000 description 2
- 238000003199 nucleic acid amplification method Methods 0.000 description 2
- 208000010626 plasma cell neoplasm Diseases 0.000 description 2
- 238000003752 polymerase chain reaction Methods 0.000 description 2
- 229920002477 rna polymer Polymers 0.000 description 2
- 206010041823 squamous cell carcinoma Diseases 0.000 description 2
- 210000002784 stomach Anatomy 0.000 description 2
- 201000008205 supratentorial primitive neuroectodermal tumor Diseases 0.000 description 2
- 230000004083 survival effect Effects 0.000 description 2
- 208000008732 thymoma Diseases 0.000 description 2
- 201000002510 thyroid cancer Diseases 0.000 description 2
- 208000029729 tumor suppressor gene on chromosome 11 Diseases 0.000 description 2
- 208000030507 AIDS Diseases 0.000 description 1
- 208000002008 AIDS-Related Lymphoma Diseases 0.000 description 1
- 208000024893 Acute lymphoblastic leukemia Diseases 0.000 description 1
- 208000014697 Acute lymphocytic leukaemia Diseases 0.000 description 1
- 206010052747 Adenocarcinoma pancreas Diseases 0.000 description 1
- 206010061424 Anal cancer Diseases 0.000 description 1
- 208000007860 Anus Neoplasms Diseases 0.000 description 1
- 108091023037 Aptamer Proteins 0.000 description 1
- 206010003571 Astrocytoma Diseases 0.000 description 1
- 208000032791 BCR-ABL1 positive chronic myelogenous leukemia Diseases 0.000 description 1
- 206010004146 Basal cell carcinoma Diseases 0.000 description 1
- 206010005003 Bladder cancer Diseases 0.000 description 1
- 208000011691 Burkitt lymphomas Diseases 0.000 description 1
- 206010007275 Carcinoid tumour Diseases 0.000 description 1
- 206010007279 Carcinoid tumour of the gastrointestinal tract Diseases 0.000 description 1
- 208000010833 Chronic myeloid leukaemia Diseases 0.000 description 1
- 206010052360 Colorectal adenocarcinoma Diseases 0.000 description 1
- 208000009798 Craniopharyngioma Diseases 0.000 description 1
- 102100028843 DNA mismatch repair protein Mlh1 Human genes 0.000 description 1
- 102100034157 DNA mismatch repair protein Msh2 Human genes 0.000 description 1
- 102100021147 DNA mismatch repair protein Msh6 Human genes 0.000 description 1
- 201000008228 Ependymoblastoma Diseases 0.000 description 1
- 206010014967 Ependymoma Diseases 0.000 description 1
- 206010014968 Ependymoma malignant Diseases 0.000 description 1
- 208000006168 Ewing Sarcoma Diseases 0.000 description 1
- 208000017259 Extragonadal germ cell tumor Diseases 0.000 description 1
- 208000022072 Gallbladder Neoplasms Diseases 0.000 description 1
- 206010051066 Gastrointestinal stromal tumour Diseases 0.000 description 1
- 208000021309 Germ cell tumor Diseases 0.000 description 1
- 208000032612 Glial tumor Diseases 0.000 description 1
- 206010018338 Glioma Diseases 0.000 description 1
- 101001134036 Homo sapiens DNA mismatch repair protein Msh2 Proteins 0.000 description 1
- 101000968658 Homo sapiens DNA mismatch repair protein Msh6 Proteins 0.000 description 1
- 208000007766 Kaposi sarcoma Diseases 0.000 description 1
- 201000005099 Langerhans cell histiocytosis Diseases 0.000 description 1
- 208000031671 Large B-Cell Diffuse Lymphoma Diseases 0.000 description 1
- 206010023825 Laryngeal cancer Diseases 0.000 description 1
- 206010061523 Lip and/or oral cavity cancer Diseases 0.000 description 1
- 206010062038 Lip neoplasm Diseases 0.000 description 1
- 206010025312 Lymphoma AIDS related Diseases 0.000 description 1
- 229910015837 MSH2 Inorganic materials 0.000 description 1
- 208000030070 Malignant epithelial tumor of ovary Diseases 0.000 description 1
- 206010061269 Malignant peritoneal neoplasm Diseases 0.000 description 1
- 208000000172 Medulloblastoma Diseases 0.000 description 1
- 208000002030 Merkel cell carcinoma Diseases 0.000 description 1
- 206010027406 Mesothelioma Diseases 0.000 description 1
- 108010074346 Mismatch Repair Endonuclease PMS2 Proteins 0.000 description 1
- 102100037480 Mismatch repair endonuclease PMS2 Human genes 0.000 description 1
- 208000003445 Mouth Neoplasms Diseases 0.000 description 1
- 108010026664 MutL Protein Homolog 1 Proteins 0.000 description 1
- 201000003793 Myelodysplastic syndrome Diseases 0.000 description 1
- 208000033761 Myelogenous Chronic BCR-ABL Positive Leukemia Diseases 0.000 description 1
- 208000033776 Myeloid Acute Leukemia Diseases 0.000 description 1
- 206010028729 Nasal cavity cancer Diseases 0.000 description 1
- 206010028767 Nasal sinus cancer Diseases 0.000 description 1
- 208000002454 Nasopharyngeal Carcinoma Diseases 0.000 description 1
- 206010061306 Nasopharyngeal cancer Diseases 0.000 description 1
- 208000034176 Neoplasms, Germ Cell and Embryonal Diseases 0.000 description 1
- 206010029266 Neuroendocrine carcinoma of the skin Diseases 0.000 description 1
- 201000010133 Oligodendroglioma Diseases 0.000 description 1
- 206010031096 Oropharyngeal cancer Diseases 0.000 description 1
- 206010057444 Oropharyngeal neoplasm Diseases 0.000 description 1
- 206010061328 Ovarian epithelial cancer Diseases 0.000 description 1
- 206010061535 Ovarian neoplasm Diseases 0.000 description 1
- 206010061902 Pancreatic neoplasm Diseases 0.000 description 1
- 208000003937 Paranasal Sinus Neoplasms Diseases 0.000 description 1
- 208000000821 Parathyroid Neoplasms Diseases 0.000 description 1
- 206010061336 Pelvic neoplasm Diseases 0.000 description 1
- 206010051949 Peritoneal sarcoma Diseases 0.000 description 1
- 206010050487 Pinealoblastoma Diseases 0.000 description 1
- 208000007913 Pituitary Neoplasms Diseases 0.000 description 1
- 201000007552 Pituitary carcinoma Diseases 0.000 description 1
- 208000002664 Pleural Solitary Fibrous Tumor Diseases 0.000 description 1
- 201000008199 Pleuropulmonary blastoma Diseases 0.000 description 1
- 208000006664 Precursor Cell Lymphoblastic Leukemia-Lymphoma Diseases 0.000 description 1
- 206010038111 Recurrent cancer Diseases 0.000 description 1
- 208000006265 Renal cell carcinoma Diseases 0.000 description 1
- 201000000582 Retinoblastoma Diseases 0.000 description 1
- 206010039491 Sarcoma Diseases 0.000 description 1
- 208000000453 Skin Neoplasms Diseases 0.000 description 1
- 206010068771 Soft tissue neoplasm Diseases 0.000 description 1
- 208000021712 Soft tissue sarcoma Diseases 0.000 description 1
- 208000000102 Squamous Cell Carcinoma of Head and Neck Diseases 0.000 description 1
- 208000031673 T-Cell Cutaneous Lymphoma Diseases 0.000 description 1
- 201000009365 Thymic carcinoma Diseases 0.000 description 1
- 208000033781 Thyroid carcinoma Diseases 0.000 description 1
- 208000007097 Urinary Bladder Neoplasms Diseases 0.000 description 1
- 201000005969 Uveal melanoma Diseases 0.000 description 1
- 208000033559 Waldenström macroglobulinemia Diseases 0.000 description 1
- 208000008383 Wilms tumor Diseases 0.000 description 1
- 208000020990 adrenal cortex carcinoma Diseases 0.000 description 1
- 208000007128 adrenocortical carcinoma Diseases 0.000 description 1
- 230000004075 alteration Effects 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 201000011165 anus cancer Diseases 0.000 description 1
- 238000013528 artificial neural network Methods 0.000 description 1
- 208000026900 bile duct neoplasm Diseases 0.000 description 1
- 210000004556 brain Anatomy 0.000 description 1
- 208000002458 carcinoid tumor Diseases 0.000 description 1
- 208000006990 cholangiocarcinoma Diseases 0.000 description 1
- 238000007635 classification algorithm Methods 0.000 description 1
- 208000029742 colonic neoplasm Diseases 0.000 description 1
- 201000007241 cutaneous T cell lymphoma Diseases 0.000 description 1
- 208000017763 cutaneous neuroendocrine carcinoma Diseases 0.000 description 1
- 238000012217 deletion Methods 0.000 description 1
- 230000037430 deletion Effects 0.000 description 1
- 206010012818 diffuse large B-cell lymphoma Diseases 0.000 description 1
- 208000037828 epithelial carcinoma Diseases 0.000 description 1
- 208000010932 epithelial neoplasm Diseases 0.000 description 1
- 201000008135 extrahepatic bile duct adenocarcinoma Diseases 0.000 description 1
- 201000008819 extrahepatic bile duct carcinoma Diseases 0.000 description 1
- 238000000684 flow cytometry Methods 0.000 description 1
- 239000012634 fragment Substances 0.000 description 1
- 230000004927 fusion Effects 0.000 description 1
- 201000010175 gallbladder cancer Diseases 0.000 description 1
- 201000006585 gastric adenocarcinoma Diseases 0.000 description 1
- 201000006972 gastroesophageal adenocarcinoma Diseases 0.000 description 1
- 210000004392 genitalia Anatomy 0.000 description 1
- 201000007116 gestational trophoblastic neoplasm Diseases 0.000 description 1
- 208000005017 glioblastoma Diseases 0.000 description 1
- 201000010536 head and neck cancer Diseases 0.000 description 1
- 201000003911 head and neck carcinoma Diseases 0.000 description 1
- 208000014829 head and neck neoplasm Diseases 0.000 description 1
- 201000000459 head and neck squamous cell carcinoma Diseases 0.000 description 1
- 238000012165 high-throughput sequencing Methods 0.000 description 1
- 238000009396 hybridization Methods 0.000 description 1
- 238000003018 immunoassay Methods 0.000 description 1
- 238000007901 in situ hybridization Methods 0.000 description 1
- 238000003780 insertion Methods 0.000 description 1
- 230000037431 insertion Effects 0.000 description 1
- 210000003734 kidney Anatomy 0.000 description 1
- 206010023841 laryngeal neoplasm Diseases 0.000 description 1
- 201000006721 lip cancer Diseases 0.000 description 1
- 201000007270 liver cancer Diseases 0.000 description 1
- 208000014018 liver neoplasm Diseases 0.000 description 1
- 238000007477 logistic regression Methods 0.000 description 1
- 208000030173 low grade glioma Diseases 0.000 description 1
- 201000001142 lung small cell carcinoma Diseases 0.000 description 1
- 208000015486 malignant pancreatic neoplasm Diseases 0.000 description 1
- 208000026045 malignant tumor of parathyroid gland Diseases 0.000 description 1
- 201000001441 melanoma Diseases 0.000 description 1
- 210000000716 merkel cell Anatomy 0.000 description 1
- 230000001394 metastastic effect Effects 0.000 description 1
- 208000037819 metastatic cancer Diseases 0.000 description 1
- 208000011575 metastatic malignant neoplasm Diseases 0.000 description 1
- 206010061289 metastatic neoplasm Diseases 0.000 description 1
- 238000002493 microarray Methods 0.000 description 1
- 230000033607 mismatch repair Effects 0.000 description 1
- 230000035772 mutation Effects 0.000 description 1
- 201000000050 myeloid neoplasm Diseases 0.000 description 1
- 201000011216 nasopharynx carcinoma Diseases 0.000 description 1
- 201000008026 nephroblastoma Diseases 0.000 description 1
- 201000011519 neuroendocrine tumor Diseases 0.000 description 1
- 201000005443 oral cavity cancer Diseases 0.000 description 1
- 201000006958 oropharynx cancer Diseases 0.000 description 1
- 201000008968 osteosarcoma Diseases 0.000 description 1
- 230000002611 ovarian Effects 0.000 description 1
- 201000002094 pancreatic adenocarcinoma Diseases 0.000 description 1
- 201000002528 pancreatic cancer Diseases 0.000 description 1
- 208000008443 pancreatic carcinoma Diseases 0.000 description 1
- 208000003154 papilloma Diseases 0.000 description 1
- 208000029211 papillomatosis Diseases 0.000 description 1
- 201000007052 paranasal sinus cancer Diseases 0.000 description 1
- 201000002524 peritoneal carcinoma Diseases 0.000 description 1
- 208000020943 pineal parenchymal cell neoplasm Diseases 0.000 description 1
- 201000003113 pineoblastoma Diseases 0.000 description 1
- 208000011866 pituitary adenocarcinoma Diseases 0.000 description 1
- 208000025638 primary cutaneous T-cell non-Hodgkin lymphoma Diseases 0.000 description 1
- 208000029340 primitive neuroectodermal tumor Diseases 0.000 description 1
- 230000002035 prolonged effect Effects 0.000 description 1
- 201000005825 prostate adenocarcinoma Diseases 0.000 description 1
- 230000002685 pulmonary effect Effects 0.000 description 1
- 238000012175 pyrosequencing Methods 0.000 description 1
- 208000010639 renal pelvis urothelial carcinoma Diseases 0.000 description 1
- 230000001850 reproductive effect Effects 0.000 description 1
- 230000004043 responsiveness Effects 0.000 description 1
- 201000009571 retroperitoneal cancer Diseases 0.000 description 1
- 201000004846 retroperitoneal sarcoma Diseases 0.000 description 1
- 201000004847 retroperitoneum carcinoma Diseases 0.000 description 1
- 201000009410 rhabdomyosarcoma Diseases 0.000 description 1
- 201000000849 skin cancer Diseases 0.000 description 1
- 208000000649 small cell carcinoma Diseases 0.000 description 1
- 208000000587 small cell lung carcinoma Diseases 0.000 description 1
- 206010062261 spinal cord neoplasm Diseases 0.000 description 1
- 210000002536 stromal cell Anatomy 0.000 description 1
- 238000006467 substitution reaction Methods 0.000 description 1
- 238000012706 support-vector machine Methods 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 208000013077 thyroid gland carcinoma Diseases 0.000 description 1
- 206010044412 transitional cell carcinoma Diseases 0.000 description 1
- 230000005945 translocation Effects 0.000 description 1
- 210000000626 ureter Anatomy 0.000 description 1
- 201000000334 ureter transitional cell carcinoma Diseases 0.000 description 1
- 201000005112 urinary bladder cancer Diseases 0.000 description 1
Priority Applications (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2024049383A JP7798947B2 (ja) | 2018-11-30 | 2024-03-26 | 次世代分子プロファイリング |
| JP2025281289A JP2026048991A (ja) | 2018-11-30 | 2025-12-25 | 次世代分子プロファイリング |
Applications Claiming Priority (7)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201862774082P | 2018-11-30 | 2018-11-30 | |
| US62/774,082 | 2018-11-30 | ||
| US201962788689P | 2019-01-04 | 2019-01-04 | |
| US62/788,689 | 2019-01-04 | ||
| US201962789495P | 2019-01-07 | 2019-01-07 | |
| US62/789,495 | 2019-01-07 | ||
| PCT/US2019/064078 WO2020113237A1 (en) | 2018-11-30 | 2019-12-02 | Next-generation molecular profiling |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024049383A Division JP7798947B2 (ja) | 2018-11-30 | 2024-03-26 | 次世代分子プロファイリング |
Publications (4)
| Publication Number | Publication Date |
|---|---|
| JP2022512080A JP2022512080A (ja) | 2022-02-02 |
| JPWO2020113237A5 true JPWO2020113237A5 (https=) | 2023-02-03 |
| JP2022512080A5 JP2022512080A5 (https=) | 2023-02-03 |
| JP7462632B2 JP7462632B2 (ja) | 2024-04-05 |
Family
ID=70853593
Family Applications (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021530882A Active JP7462632B2 (ja) | 2018-11-30 | 2019-12-02 | 次世代分子プロファイリング |
| JP2024049383A Active JP7798947B2 (ja) | 2018-11-30 | 2024-03-26 | 次世代分子プロファイリング |
| JP2025281289A Pending JP2026048991A (ja) | 2018-11-30 | 2025-12-25 | 次世代分子プロファイリング |
Family Applications After (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024049383A Active JP7798947B2 (ja) | 2018-11-30 | 2024-03-26 | 次世代分子プロファイリング |
| JP2025281289A Pending JP2026048991A (ja) | 2018-11-30 | 2025-12-25 | 次世代分子プロファイリング |
Country Status (9)
| Country | Link |
|---|---|
| US (3) | US11315673B2 (https=) |
| EP (2) | EP3888021B1 (https=) |
| JP (3) | JP7462632B2 (https=) |
| KR (1) | KR20210111254A (https=) |
| AU (2) | AU2019389175B2 (https=) |
| CA (1) | CA3121170A1 (https=) |
| IL (2) | IL311084B1 (https=) |
| MX (1) | MX2021006234A (https=) |
| WO (1) | WO2020113237A1 (https=) |
Families Citing this family (26)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP7462632B2 (ja) | 2018-11-30 | 2024-04-05 | カリス エムピーアイ インコーポレイテッド | 次世代分子プロファイリング |
| US11942189B2 (en) * | 2019-01-16 | 2024-03-26 | International Business Machines Corporation | Drug efficacy prediction for treatment of genetic disease |
| WO2021112918A1 (en) | 2019-12-02 | 2021-06-10 | Caris Mpi, Inc. | Pan-cancer platinum response predictor |
| EP4070320B1 (en) * | 2019-12-05 | 2024-11-27 | Illumina, Inc. | Rapid detection of gene fusions |
| EP4100955A4 (en) * | 2020-02-06 | 2024-02-28 | Oncohost Ltd | MACHINE LEARNING PREDICTION OF THERAPEUTIC RESPONSE |
| CN111767390B (zh) * | 2020-06-28 | 2025-05-30 | 北京百度网讯科技有限公司 | 技能词评估方法及装置、电子设备、计算机可读介质 |
| WO2022029488A1 (en) * | 2020-08-06 | 2022-02-10 | Agenda Nv | Systems and methods of assessing breast cancer |
| US11335443B1 (en) | 2020-09-07 | 2022-05-17 | OpenNano Pte. Ltd. | Phenotypic patient data derivation from economic data |
| EP4229214A4 (en) * | 2020-10-14 | 2024-08-28 | Imprimed, Inc. | METHODS AND SYSTEMS FOR PREDICTING IN VIVO RESPONSE TO DRUG THERAPIES |
| US11954859B2 (en) | 2020-11-11 | 2024-04-09 | Agendia NV | Methods of assessing diseases using image classifiers |
| US11426117B2 (en) * | 2020-12-29 | 2022-08-30 | Kpn Innovations, Llc. | Methods and systems for dietary communications using intelligent systems regarding endocrinal measurements |
| CN112768076B (zh) * | 2021-02-01 | 2023-11-21 | 华中科技大学同济医学院附属协和医院 | 一种食管癌化疗发生骨髓抑制的风险预测模型构建方法 |
| US11550580B2 (en) * | 2021-02-24 | 2023-01-10 | Northrop Grumman Systems Corporation | Systems and methods for emulating a processor |
| JP2024522064A (ja) * | 2021-05-18 | 2024-06-11 | ヴェン バイオサイエンシーズ コーポレーション | 卵巣癌を診断するためのバイオマーカー |
| KR20240068638A (ko) | 2021-08-16 | 2024-05-17 | 인시트로, 인코포레이티드 | 발견 플랫폼 |
| WO2023092108A2 (en) | 2021-11-19 | 2023-05-25 | Insitro, Inc. | Autonomous cell imaging and modeling system |
| WO2023164665A1 (en) * | 2022-02-25 | 2023-08-31 | Fred Hutchinson Cancer Center | Machine learning applications to predict biological outcomes and elucidate underlying biological mechanisms |
| US12217297B2 (en) * | 2022-05-17 | 2025-02-04 | Dell Products L.P. | Hyper-segmented personalization using machine learning-based models in an information processing system |
| WO2024006639A2 (en) * | 2022-06-27 | 2024-01-04 | Deep Rx Inc. | Machine-learning computer systems and methods for predicting efficacy of chemical and biological agents for treating diseases, such as gastrointestinal cancers |
| JP7266349B1 (ja) * | 2022-08-19 | 2023-04-28 | 株式会社ＵＴ－Ｈｅａｒｔ研究所 | インシリコ心疾患データベース活用方法、インシリコ心疾患データベース活用プログラム、および情報処理装置 |
| EP4586891A1 (en) * | 2022-09-13 | 2025-07-23 | The Open University Of Israel | System and method of predicting a gene expression profile |
| CN115631849B (zh) * | 2022-10-19 | 2023-04-28 | 哈尔滨工业大学 | 基于深度神经网络的乳腺癌预后指示系统、存储介质及设备 |
| WO2024173610A1 (en) | 2023-02-15 | 2024-08-22 | Insitro, Inc. | Machine-learning-enabled predictive biomarker discovery and patient stratification using standard-of-care data |
| WO2024249579A2 (en) * | 2023-05-30 | 2024-12-05 | The Trustees Of Columbia University In The City Of New York | System, method, and program product for out of distribution generalization via interventional style transfer |
| US20250046461A1 (en) * | 2023-08-03 | 2025-02-06 | Anumana, Inc. | Apparatus and method for determining a patient survival profile using artificial intelligence-enabled electrocardiogram (ecg) |
| WO2025255578A1 (en) | 2024-06-07 | 2025-12-11 | Caris Mpi, Inc. | Dual-modality models for digital pathology |
Family Cites Families (284)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| NL154598B (nl) | 1970-11-10 | 1977-09-15 | Organon Nv | Werkwijze voor het aantonen en bepalen van laagmoleculire verbindingen en van eiwitten die deze verbindingen specifiek kunnen binden, alsmede testverpakking. |
| US3817837A (en) | 1971-05-14 | 1974-06-18 | Syva Corp | Enzyme amplification assay |
| US4018653A (en) | 1971-10-29 | 1977-04-19 | U.S. Packaging Corporation | Instrument for the detection of Neisseria gonorrhoeae without culture |
| US3939350A (en) | 1974-04-29 | 1976-02-17 | Board Of Trustees Of The Leland Stanford Junior University | Fluorescent immunoassay employing total reflection for activation |
| US3996345A (en) | 1974-08-12 | 1976-12-07 | Syva Company | Fluorescence quenching with immunological pairs in immunoassays |
| US4016043A (en) | 1975-09-04 | 1977-04-05 | Akzona Incorporated | Enzymatic immunological method for the determination of antigens and antibodies |
| US4437975A (en) | 1977-07-20 | 1984-03-20 | Mobil Oil Corporation | Manufacture of lube base stock oil |
| US4275149A (en) | 1978-11-24 | 1981-06-23 | Syva Company | Macromolecular environment control in specific receptor assays |
| US4277437A (en) | 1978-04-05 | 1981-07-07 | Syva Company | Kit for carrying out chemically induced fluorescence immunoassay |
| US4376110A (en) | 1980-08-04 | 1983-03-08 | Hybritech, Incorporated | Immunometric assays using monoclonal antibodies |
| US4486530A (en) | 1980-08-04 | 1984-12-04 | Hybritech Incorporated | Immunometric assays using monoclonal antibodies |
| US4366241A (en) | 1980-08-07 | 1982-12-28 | Syva Company | Concentrating zone method in heterogeneous immunoassays |
| US4424279A (en) | 1982-08-12 | 1984-01-03 | Quidel | Rapid plunger immunoassay method and apparatus |
| GB8311018D0 (en) | 1983-04-22 | 1983-05-25 | Amersham Int Plc | Detecting mutations in dna |
| US4666828A (en) | 1984-08-15 | 1987-05-19 | The General Hospital Corporation | Test for Huntington's disease |
| US5242794A (en) | 1984-12-13 | 1993-09-07 | Applied Biosystems, Inc. | Detection of specific sequences in nucleic acids |
| US4683202A (en) | 1985-03-28 | 1987-07-28 | Cetus Corporation | Process for amplifying nucleic acid sequences |
| US5333675C1 (en) | 1986-02-25 | 2001-05-01 | Perkin Elmer Corp | Apparatus and method for performing automated amplification of nucleic acid sequences and assays using heating and cooling steps |
| US5656493A (en) | 1985-03-28 | 1997-08-12 | The Perkin-Elmer Corporation | System for automated performance of the polymerase chain reaction |
| US4965188A (en) | 1986-08-22 | 1990-10-23 | Cetus Corporation | Process for amplifying, detecting, and/or cloning nucleic acid sequences using a thermostable enzyme |
| US4683195A (en) | 1986-01-30 | 1987-07-28 | Cetus Corporation | Process for amplifying, detecting, and/or-cloning nucleic acid sequences |
| US4801531A (en) | 1985-04-17 | 1989-01-31 | Biotechnology Research Partners, Ltd. | Apo AI/CIII genomic polymorphisms predictive of atherosclerosis |
| US4800159A (en) | 1986-02-07 | 1989-01-24 | Cetus Corporation | Process for amplifying, detecting, and/or cloning nucleic acid sequences |
| US4851331A (en) | 1986-05-16 | 1989-07-25 | Allied Corporation | Method and kit for polynucleotide assay including primer-dependant DNA polymerase |
| IL86724A (en) | 1987-06-19 | 1995-01-24 | Siska Diagnostics Inc | Methods and kits for amplification and testing of nucleic acid sequences |
| CA1340843C (en) | 1987-07-31 | 1999-12-07 | J. Lawrence Burg | Selective amplification of target polynucleotide sequences |
| JP2650159B2 (ja) | 1988-02-24 | 1997-09-03 | アクゾ・ノベル・エヌ・ベー | 核酸増幅方法 |
| CA1340807C (en) | 1988-02-24 | 1999-11-02 | Lawrence T. Malek | Nucleic acid amplification process |
| IE61148B1 (en) | 1988-03-10 | 1994-10-05 | Ici Plc | Method of detecting nucleotide sequences |
| US4988617A (en) | 1988-03-25 | 1991-01-29 | California Institute Of Technology | Method of detecting a nucleotide change in nucleic acids |
| US5137765A (en) | 1988-08-05 | 1992-08-11 | Porton Instruments, Inc. | Derivatized glass supports for peptide and protein sequencing |
| US5272057A (en) | 1988-10-14 | 1993-12-21 | Georgetown University | Method of detecting a predisposition to cancer by the use of restriction fragment length polymorphism of the gene for human poly (ADP-ribose) polymerase |
| CA2005589C (en) | 1988-12-16 | 2001-02-06 | Akzo Nobel Nv | Self-sustained, sequence replication system |
| US5856092A (en) | 1989-02-13 | 1999-01-05 | Geneco Pty Ltd | Detection of a nucleic acid sequence or a change therein |
| US5424186A (en) | 1989-06-07 | 1995-06-13 | Affymax Technologies N.V. | Very large scale immobilized polymer synthesis |
| US5242974A (en) | 1991-11-22 | 1993-09-07 | Affymax Technologies N.V. | Polymer reversal on solid surfaces |
| US5547839A (en) | 1989-06-07 | 1996-08-20 | Affymax Technologies N.V. | Sequencing of surface immobilized polymers utilizing microflourescence detection |
| US5800992A (en) | 1989-06-07 | 1998-09-01 | Fodor; Stephen P.A. | Method of detecting nucleic acids |
| US6346413B1 (en) | 1989-06-07 | 2002-02-12 | Affymetrix, Inc. | Polymer arrays |
| US5143854A (en) | 1989-06-07 | 1992-09-01 | Affymax Technologies N.V. | Large scale photolithographic solid phase synthesis of polypeptides and receptor binding screening thereof |
| US5744101A (en) | 1989-06-07 | 1998-04-28 | Affymax Technologies N.V. | Photolabile nucleoside protecting groups |
| US5527681A (en) | 1989-06-07 | 1996-06-18 | Affymax Technologies N.V. | Immobilized molecular synthesis of systematically substituted compounds |
| US5871928A (en) | 1989-06-07 | 1999-02-16 | Fodor; Stephen P. A. | Methods for nucleic acid analysis |
| US5925525A (en) | 1989-06-07 | 1999-07-20 | Affymetrix, Inc. | Method of identifying nucleotide differences |
| US5192659A (en) | 1989-08-25 | 1993-03-09 | Genetype Ag | Intron sequence analysis method for detection of adjacent and remote locus alleles as haplotypes |
| US5252743A (en) | 1989-11-13 | 1993-10-12 | Affymax Technologies N.V. | Spatially-addressable immobilization of anti-ligands on surfaces |
| US6013431A (en) | 1990-02-16 | 2000-01-11 | Molecular Tool, Inc. | Method for determining specific nucleotide variations by primer extension in the presence of mixture of labeled nucleotides and terminators |
| US5494810A (en) | 1990-05-03 | 1996-02-27 | Cornell Research Foundation, Inc. | Thermostable ligase-mediated DNA amplifications system for the detection of genetic disease |
| US5266222A (en) | 1990-05-23 | 1993-11-30 | California Institute Of Technology | Durable low surface-energy surfaces |
| DE69128545D1 (de) | 1990-08-24 | 1998-02-05 | Univ Tennessee Res Corp | Technik des genetischen fingerabdrucks mit dns-vervielfältigung |
| WO1992007095A1 (en) | 1990-10-15 | 1992-04-30 | Stratagene | Arbitrarily primed polymerase chain reaction method for fingerprinting genomes |
| US6004744A (en) | 1991-03-05 | 1999-12-21 | Molecular Tool, Inc. | Method for determining nucleotide identity through extension of immobilized primer |
| DE4214112A1 (de) | 1991-08-02 | 1993-02-04 | Europ Lab Molekularbiolog | Neues verfahren zur sequenzierung von nukleinsaeuren |
| DE69233501T2 (de) | 1991-11-22 | 2006-02-23 | Affymetrix, Inc. (n.d.Ges.d.Staates Delaware), Santa Clara | Kombinatorische Strategien für die Polymersynthese |
| US5550215A (en) | 1991-11-22 | 1996-08-27 | Holmes; Christopher P. | Polymer reversal on solid surfaces |
| US5412087A (en) | 1992-04-24 | 1995-05-02 | Affymax Technologies N.V. | Spatially-addressable immobilization of oligonucleotides and other biological polymers on surfaces |
| US5384261A (en) | 1991-11-22 | 1995-01-24 | Affymax Technologies N.V. | Very large scale immobilized polymer synthesis using mechanically directed flow paths |
| US5324633A (en) | 1991-11-22 | 1994-06-28 | Affymax Technologies N.V. | Method and apparatus for measuring binding affinity |
| US5965362A (en) | 1992-03-04 | 1999-10-12 | The Regents Of The University Of California | Comparative genomic hybridization (CGH) |
| GB9208733D0 (en) | 1992-04-22 | 1992-06-10 | Medical Res Council | Dna sequencing method |
| GB9211979D0 (en) | 1992-06-05 | 1992-07-15 | Buchard Ole | Uses of nucleic acid analogues |
| US5605798A (en) | 1993-01-07 | 1997-02-25 | Sequenom, Inc. | DNA diagnostic based on mass spectrometry |
| CA2153387A1 (en) | 1993-01-07 | 1994-07-21 | Hubert Koester | Dna sequencing by mass spectrometry |
| US6194144B1 (en) | 1993-01-07 | 2001-02-27 | Sequenom, Inc. | DNA sequencing by mass spectrometry |
| US5491074A (en) | 1993-04-01 | 1996-02-13 | Affymax Technologies Nv | Association peptides |
| US5858659A (en) | 1995-11-29 | 1999-01-12 | Affymetrix, Inc. | Polymorphism detection |
| US5837832A (en) | 1993-06-25 | 1998-11-17 | Affymetrix, Inc. | Arrays of nucleic acid probes on biological chips |
| US6045996A (en) | 1993-10-26 | 2000-04-04 | Affymetrix, Inc. | Hybridization assays on oligonucleotide arrays |
| EP0765401B1 (en) | 1993-11-17 | 2001-02-21 | Amersham Pharmacia Biotech UK Limited | Primer extension mass spectroscopy nucleic acid sequencing method |
| EP0754240B1 (en) | 1994-02-07 | 2003-08-20 | Beckman Coulter, Inc. | Ligase/polymerase-mediated genetic bit analysis of single nucleotide polymorphisms and its use in genetic analysis |
| US5631734A (en) | 1994-02-10 | 1997-05-20 | Affymetrix, Inc. | Method and apparatus for detection of fluorescently labeled materials |
| US5578832A (en) | 1994-09-02 | 1996-11-26 | Affymetrix, Inc. | Method and apparatus for imaging a sample on a device |
| US6090555A (en) | 1997-12-11 | 2000-07-18 | Affymetrix, Inc. | Scanned image alignment systems and methods |
| AU693198B2 (en) | 1994-04-25 | 1998-06-25 | Avitech Diagnostics, Inc. | Detection of mutation by resolvase cleavage |
| US5851770A (en) | 1994-04-25 | 1998-12-22 | Variagenics, Inc. | Detection of mismatches by resolvase cleavage using a magnetic bead support |
| WO1995030774A1 (en) | 1994-05-05 | 1995-11-16 | Beckman Instruments, Inc. | Oligonucleotide repeat arrays |
| US5571639A (en) | 1994-05-24 | 1996-11-05 | Affymax Technologies N.V. | Computer-aided engineering system for design of sequence arrays and lithographic masks |
| US5834189A (en) | 1994-07-08 | 1998-11-10 | Visible Genetics Inc. | Method for evaluation of polymorphic genetic sequences, and the use thereof in identification of HLA types |
| US5795716A (en) | 1994-10-21 | 1998-08-18 | Chee; Mark S. | Computer-aided visualization and analysis system for sequence evaluation |
| US5959098A (en) | 1996-04-17 | 1999-09-28 | Affymetrix, Inc. | Substrate preparation process |
| US5599695A (en) | 1995-02-27 | 1997-02-04 | Affymetrix, Inc. | Printing molecular library arrays using deprotection agents solely in the vapor phase |
| US5624711A (en) | 1995-04-27 | 1997-04-29 | Affymax Technologies, N.V. | Derivatization of solid supports and methods for oligomer synthesis |
| DE19515552A1 (de) | 1995-04-27 | 1996-10-31 | Europ Lab Molekularbiolog | Simultane Sequenzierung von Nukleinsäuren |
| US5545531A (en) | 1995-06-07 | 1996-08-13 | Affymax Technologies N.V. | Methods for making a device for concurrently processing multiple biological chip assays |
| US5981186A (en) | 1995-06-30 | 1999-11-09 | Visible Genetics, Inc. | Method and apparatus for DNA-sequencing using reduced number of sequencing mixtures |
| US5968740A (en) | 1995-07-24 | 1999-10-19 | Affymetrix, Inc. | Method of Identifying a Base in a Nucleic Acid |
| US5733729A (en) | 1995-09-14 | 1998-03-31 | Affymetrix, Inc. | Computer-aided probability base calling for arrays of nucleic acid probes on chips |
| JP3193301B2 (ja) | 1995-09-14 | 2001-07-30 | 麒麟麦酒株式会社 | 生理活性タンパク質ｐ１６０ |
| US5869242A (en) | 1995-09-18 | 1999-02-09 | Myriad Genetics, Inc. | Mass spectrometry to assess DNA sequence polymorphisms |
| US6147205A (en) | 1995-12-15 | 2000-11-14 | Affymetrix, Inc. | Photocleavable protecting groups and methods for their use |
| US6114122A (en) | 1996-03-26 | 2000-09-05 | Affymetrix, Inc. | Fluidics station with a mounting system and method of using |
| US5928906A (en) | 1996-05-09 | 1999-07-27 | Sequenom, Inc. | Process for direct sequencing during template amplification |
| WO1997043611A1 (en) | 1996-05-16 | 1997-11-20 | Affymetrix, Inc. | Systems and methods for detection of labeled materials |
| US5786146A (en) | 1996-06-03 | 1998-07-28 | The Johns Hopkins University School Of Medicine | Method of detection of methylated nucleic acid using agents which modify unmethylated cytosine and distinguishing modified methylated and non-methylated nucleic acids |
| EP0912752A1 (en) | 1996-06-14 | 1999-05-06 | Sarnoff Corporation | Method for polynucleotide sequencing |
| GB9620209D0 (en) | 1996-09-27 | 1996-11-13 | Cemu Bioteknik Ab | Method of sequencing DNA |
| US6017702A (en) | 1996-12-05 | 2000-01-25 | The Perkin-Elmer Corporation | Chain-termination type nucleic acid sequencing method including 2'-deoxyuridine-5'-triphosphate |
| US5876934A (en) | 1996-12-18 | 1999-03-02 | Pharmacia Biotech Inc. | DNA sequencing method |
| US6046005A (en) | 1997-01-15 | 2000-04-04 | Incyte Pharmaceuticals, Inc. | Nucleic acid sequencing with solid phase capturable terminators comprising a cleavable linking group |
| US6586806B1 (en) | 1997-06-20 | 2003-07-01 | Cypress Semiconductor Corporation | Method and structure for a single-sided non-self-aligned transistor |
| US6420108B2 (en) | 1998-02-09 | 2002-07-16 | Affymetrix, Inc. | Computer-aided display for comparative gene expression |
| JP2001515234A (ja) | 1997-07-25 | 2001-09-18 | アフィメトリックス インコーポレイテッド | 多型性データベースを提供するためのシステム |
| US6223127B1 (en) | 1997-08-15 | 2001-04-24 | Affymetrix, Inc. | Polymorphism detection utilizing clustering analysis |
| EP1027456B1 (en) | 1997-10-31 | 2005-03-16 | Affymetrix, Inc. (a Delaware Corporation) | Expression profiles in adult and fetal organs |
| US5998143A (en) | 1997-12-05 | 1999-12-07 | The Perkin-Elmer Corporation | Cycle sequencing thermal profiles |
| US6201639B1 (en) | 1998-03-20 | 2001-03-13 | James W. Overbeck | Wide field of view and high speed scanning microscopy |
| US6269846B1 (en) | 1998-01-13 | 2001-08-07 | Genetic Microsystems, Inc. | Depositing fluid specimens on substrates, resulting ordered arrays, techniques for deposition of arrays |
| US6428752B1 (en) | 1998-05-14 | 2002-08-06 | Affymetrix, Inc. | Cleaning deposit devices that form microarrays and the like |
| AU753273B2 (en) | 1998-02-04 | 2002-10-10 | Variagenics, Inc. | Mismatch detection techniques |
| US6185030B1 (en) | 1998-03-20 | 2001-02-06 | James W. Overbeck | Wide field of view and high speed scanning microscopy |
| US5936324A (en) | 1998-03-30 | 1999-08-10 | Genetic Microsystems Inc. | Moving magnet scanner |
| US7805388B2 (en) * | 1998-05-01 | 2010-09-28 | Health Discovery Corporation | Method for feature selection in a support vector machine using feature ranking |
| US6183958B1 (en) | 1998-05-06 | 2001-02-06 | Variagenics, Inc. | Probes for variance detection |
| JP3565025B2 (ja) | 1998-07-07 | 2004-09-15 | 日産自動車株式会社 | 治具交換装置および治具交換方法 |
| US6185561B1 (en) | 1998-09-17 | 2001-02-06 | Affymetrix, Inc. | Method and apparatus for providing and expression data mining database |
| US6140054A (en) | 1998-09-30 | 2000-10-31 | University Of Utah Research Foundation | Multiplex genotyping using fluorescent hybridization probes |
| US6262216B1 (en) | 1998-10-13 | 2001-07-17 | Affymetrix, Inc. | Functionalized silicon compounds and methods for their synthesis and use |
| WO2000024939A1 (en) | 1998-10-27 | 2000-05-04 | Affymetrix, Inc. | Complexity management and analysis of genomic dna |
| US7700324B1 (en) | 1998-11-03 | 2010-04-20 | The Johns Hopkins University School Of Medicine | Methylated CpG island amplification (MCA) |
| NO986133D0 (no) | 1998-12-23 | 1998-12-23 | Preben Lexow | FremgangsmÕte for DNA-sekvensering |
| EP1165839A2 (en) | 1999-03-26 | 2002-01-02 | Whitehead Institute For Biomedical Research | Universal arrays |
| US6218803B1 (en) | 1999-06-04 | 2001-04-17 | Genetic Microsystems, Inc. | Position sensing with variable capacitance transducers |
| US6300070B1 (en) | 1999-06-04 | 2001-10-09 | Mosaic Technologies, Inc. | Solid phase methods for amplifying multiple nucleic acids |
| US6811668B1 (en) | 1999-06-22 | 2004-11-02 | Caliper Life Sciences, Inc. | Apparatus for the operation of a microfluidic device |
| IL147302A0 (en) | 1999-06-28 | 2002-08-14 | California Inst Of Techn | Microfabricated elastomeric valve and pump systems |
| US6274320B1 (en) | 1999-09-16 | 2001-08-14 | Curagen Corporation | Method of sequencing a nucleic acid |
| US6297016B1 (en) | 1999-10-08 | 2001-10-02 | Applera Corporation | Template-dependent ligation with PNA-DNA chimeric probes |
| US6221600B1 (en) | 1999-10-08 | 2001-04-24 | Board Of Regents, The University Of Texas System | Combinatorial oligonucleotide PCR: a method for rapid, global expression analysis |
| WO2001027327A2 (en) | 1999-10-08 | 2001-04-19 | Protogene Laboratories, Inc. | Method and apparatus for performing large numbers of reactions using array assembly |
| US6958225B2 (en) | 1999-10-27 | 2005-10-25 | Affymetrix, Inc. | Complexity management of genomic DNA |
| US7970718B2 (en) * | 2001-05-18 | 2011-06-28 | Health Discovery Corporation | Method for feature selection and for evaluating features identified as significant for classifying data |
| WO2001051918A1 (en) | 2000-01-12 | 2001-07-19 | Ut-Battelle, Llc | A microfluidic device and method for focusing, segmenting, and dispensing of a fluid stream |
| US7452713B2 (en) | 2000-02-29 | 2008-11-18 | Stmicroelectronics S.R.L. | Process for manufacturing a microfluidic device with buried channels |
| US7867763B2 (en) | 2004-01-25 | 2011-01-11 | Fluidigm Corporation | Integrated chip carriers with thermocycler interfaces and methods of using the same |
| SE0001768D0 (sv) | 2000-05-12 | 2000-05-12 | Helen Andersson | Mikrofluidisk flödescell för manipulering av partiklar |
| US6386749B1 (en) | 2000-06-26 | 2002-05-14 | Affymetrix, Inc. | Systems and methods for heating and mixing fluids |
| EP1340082A2 (en) | 2000-08-23 | 2003-09-03 | Imego AB | Microfluidic device and method with transport of magnetic particles into and out of wells |
| US20020048821A1 (en) | 2000-08-24 | 2002-04-25 | David Storek | Sample preparing arrangement and a method relating to such an arrangement |
| ATE365922T1 (de) | 2000-10-27 | 2007-07-15 | Mount Sinai Hospital Corp | Verfahren zur erkennung von eierstockkrebs mittels menschlichem kallikrein (hk6) |
| WO2002056049A2 (en) | 2000-12-01 | 2002-07-18 | Protasis Corp | Microfluidic device with multiple microcoil nmr detectors |
| US6391592B1 (en) | 2000-12-14 | 2002-05-21 | Affymetrix, Inc. | Blocker-aided target amplification of nucleic acids |
| US20020183936A1 (en) | 2001-01-24 | 2002-12-05 | Affymetrix, Inc. | Method, system, and computer software for providing a genomic web portal |
| US7323140B2 (en) | 2001-03-28 | 2008-01-29 | Handylab, Inc. | Moving microdroplets in a microfluidic device |
| US6802342B2 (en) | 2001-04-06 | 2004-10-12 | Fluidigm Corporation | Microfabricated fluidic circuit elements and applications |
| US6649348B2 (en) | 2001-06-29 | 2003-11-18 | Agilent Technologies Inc. | Methods for manufacturing arrays |
| US6585606B2 (en) | 2001-07-16 | 2003-07-01 | Thomas S. Penrose | Golf club accessory |
| US6632611B2 (en) | 2001-07-20 | 2003-10-14 | Affymetrix, Inc. | Method of target enrichment and amplification |
| US7390463B2 (en) | 2001-09-07 | 2008-06-24 | Corning Incorporated | Microcolumn-based, high-throughput microfluidic device |
| ATE477054T1 (de) | 2001-09-17 | 2010-08-15 | Gyros Patent Ab | Einen kontrollierten strom in einer mikrofluidvorrichtung ermöglichende funktionseinheit |
| US7189580B2 (en) | 2001-10-19 | 2007-03-13 | Wisconsin Alumni Research Foundation | Method of pumping fluid through a microfluidic device |
| US7253003B2 (en) | 2001-10-19 | 2007-08-07 | Wisconsin Alumni Research Foundation | Method for monitoring the environment within a microfluidic device |
| US7118910B2 (en) | 2001-11-30 | 2006-10-10 | Fluidigm Corporation | Microfluidic device and methods of using same |
| US7258837B2 (en) | 2001-12-05 | 2007-08-21 | University Of Washington | Microfluidic device and surface decoration process for solid phase affinity binding assays |
| US7238255B2 (en) | 2001-12-31 | 2007-07-03 | Gyros Patent Ab | Microfluidic device and its manufacture |
| US6958119B2 (en) | 2002-02-26 | 2005-10-25 | Agilent Technologies, Inc. | Mobile phase gradient generation microfluidic device |
| US7195986B1 (en) | 2002-03-08 | 2007-03-27 | Caliper Life Sciences, Inc. | Microfluidic device with controlled substrate conductivity |
| GB2388189B (en) | 2002-04-29 | 2006-01-11 | Robert Jeffrey Geddes Carr | Optical detection and analysis of particles |
| US7189581B2 (en) | 2002-04-30 | 2007-03-13 | Wisconsin Alumni Research Foundation | Method of obtaining a sample concentration of a solution in a microfluidic device |
| DE60228685D1 (de) | 2002-05-16 | 2008-10-16 | Micronit Microfluidics Bv | Verfahren zur Herstellung eines mikrofluidischen Bauteiles |
| US7381471B2 (en) | 2002-07-15 | 2008-06-03 | University Of Virginia Patent Foundation | Hybrid polymers for functional tuning of microfluidic device surfaces |
| US7201881B2 (en) | 2002-07-26 | 2007-04-10 | Applera Corporation | Actuator for deformable valves in a microfluidic device, and method |
| US7135147B2 (en) | 2002-07-26 | 2006-11-14 | Applera Corporation | Closing blade for deformable valve in a microfluidic device and method |
| US7452509B2 (en) | 2002-07-26 | 2008-11-18 | Applied Biosystems Inc. | Microfluidic device including displaceable material trap, and system |
| WO2004011666A2 (en) | 2002-07-26 | 2004-02-05 | Applera Corporation | Mg-mediated hot start biochemical reactions |
| KR100480338B1 (ko) | 2002-08-08 | 2005-03-30 | 한국전자통신연구원 | 극소량의 유체제어를 위한 미세 유체제어소자 |
| TW536524B (en) | 2002-09-17 | 2003-06-11 | Fan-Gen Tzeng | Network-type micro-channel device for micro-fluid |
| US7118661B2 (en) | 2002-09-30 | 2006-10-10 | The Regents Of The University Of California | Nanolaminate microfluidic device for mobility selection of particles |
| EP2719756B1 (en) | 2002-10-04 | 2017-04-05 | The Regents of the University of California | Microfluidic multi-compartment device for neuroscience research |
| FR2848125B1 (fr) | 2002-12-04 | 2006-06-09 | Commissariat Energie Atomique | Dispositif microfluidique dans lequel l'interface liquide/fluide est stabilisee |
| US7467928B2 (en) | 2002-12-12 | 2008-12-23 | Board Of Trustees Of The University Of Arkansas | Microfluidic device utilizing magnetohydrodynamics and method for fabrication thereof |
| US7125711B2 (en) | 2002-12-19 | 2006-10-24 | Bayer Healthcare Llc | Method and apparatus for splitting of specimens into multiple channels of a microfluidic device |
| US7338637B2 (en) | 2003-01-31 | 2008-03-04 | Hewlett-Packard Development Company, L.P. | Microfluidic device with thin-film electronic devices |
| US7413709B2 (en) | 2003-02-12 | 2008-08-19 | Agilent Technologies, Inc. | PAEK-based microfluidic device with integrated electrospray emitter |
| JP3856763B2 (ja) | 2003-03-11 | 2006-12-13 | 財団法人川村理化学研究所 | マイクロ流体素子の製造方法 |
| AU2004228678A1 (en) | 2003-04-03 | 2004-10-21 | Fluidigm Corp. | Microfluidic devices and methods of using same |
| US20070117164A1 (en) | 2003-04-08 | 2007-05-24 | Raskov Hans H | Method for detection of colorectal cancer in human samples |
| US7422725B2 (en) | 2003-05-01 | 2008-09-09 | Enplas Corporation | Sample handling unit applicable to microchip, and microfluidic device having microchips |
| US7544506B2 (en) | 2003-06-06 | 2009-06-09 | Micronics, Inc. | System and method for heating, cooling and heat cycling on microfluidic device |
| US20050124071A1 (en) | 2003-09-30 | 2005-06-09 | Kraus Virginia B. | Methods and compositions for diagnosing musculoskeletal, arthritic and joint disorders by biomarker dating |
| FR2862007B1 (fr) | 2003-11-12 | 2005-12-23 | Commissariat Energie Atomique | Dispositif microfluidique muni d'un nez d'electronebulisation. |
| US7329391B2 (en) | 2003-12-08 | 2008-02-12 | Applera Corporation | Microfluidic device and material manipulating method using same |
| EP1547688A1 (en) | 2003-12-23 | 2005-06-29 | STMicroelectronics S.r.l. | Microfluidic device and method of locally concentrating electrically charged substances in a microfluidic device |
| US7099778B2 (en) | 2003-12-30 | 2006-08-29 | Caliper Life Sciences, Inc. | Method for determining diffusivity and molecular weight in a microfluidic device |
| US7351380B2 (en) | 2004-01-08 | 2008-04-01 | Sandia Corporation | Microfluidic structures and methods for integrating a functional component into a microfluidic device |
| US7250260B2 (en) | 2004-02-18 | 2007-07-31 | Applera Corporation | Multi-step bioassays on modular microfluidic application platforms |
| US20060195266A1 (en) * | 2005-02-25 | 2006-08-31 | Yeatman Timothy J | Methods for predicting cancer outcome and gene signatures for use therein |
| US7402229B2 (en) | 2004-03-31 | 2008-07-22 | Intel Corporation | Fabrication and use of semipermeable membranes and gels for the control of electrolysis in a microfluidic device |
| US7575722B2 (en) | 2004-04-02 | 2009-08-18 | Eksigent Technologies, Inc. | Microfluidic device |
| US7419639B2 (en) | 2004-05-12 | 2008-09-02 | The Board Of Trustees Of The Leland Stanford Junior University | Multilayer microfluidic device |
| US7655479B2 (en) | 2004-06-30 | 2010-02-02 | University Of South Florida | Luminescence characterization of quantum dots conjugated with biomarkers for early cancer detection |
| JP2008505649A (ja) | 2004-07-09 | 2008-02-28 | アモークス リミテッド | 免疫細胞バイオセンサーおよびその使用方法 |
| US7488596B2 (en) | 2004-12-17 | 2009-02-10 | Samsung Electronics Co., Ltd. | Microfluidic device comprising electrolysis device for cell lysis and method for electrochemically lysing cells using the same |
| WO2006084132A2 (en) | 2005-02-01 | 2006-08-10 | Agencourt Bioscience Corp. | Reagents, methods, and libraries for bead-based squencing |
| WO2006115863A2 (en) | 2005-04-12 | 2006-11-02 | Caliper Life Sciences, Inc. | Compact optical detection system for microfluidic devices |
| US20090061422A1 (en) * | 2005-04-19 | 2009-03-05 | Linke Steven P | Diagnostic markers of breast cancer treatment and progression and methods of use thereof |
| KR100590581B1 (ko) | 2005-05-10 | 2006-06-19 | 삼성전자주식회사 | 미세유동장치 및 그 제조방법 |
| JP4992201B2 (ja) | 2005-06-07 | 2012-08-08 | 富士ゼロックス株式会社 | マイクロ流体制御方法、マイクロ流体素子およびその製造方法 |
| WO2007002069A2 (en) | 2005-06-21 | 2007-01-04 | Anthony Goncalves | Serum biomarkers for breast cancer |
| CA2672322A1 (en) | 2005-10-14 | 2007-04-19 | Institut De Cardiologie De Montreal | Method for detecting a biomarker of oxidative stress in a biological sample |
| US7993859B2 (en) | 2005-10-14 | 2011-08-09 | Institut De Cardiologie De Montreal | Method for quantifying oxidative stress caused by different biological pathways |
| TWI274040B (en) | 2005-12-23 | 2007-02-21 | Ind Tech Res Inst | Microfluidic device and method of manufacturing the same |
| US7568399B2 (en) | 2006-01-05 | 2009-08-04 | Integrated Sensing Systems, Inc. | Microfluidic device |
| US7581429B2 (en) | 2006-01-06 | 2009-09-01 | Integrated Sensing Systems, Inc. | Microfluidic device and method of operation |
| ATE486285T1 (de) | 2006-01-31 | 2010-11-15 | Medical Res Fund Of Tel Aviv S | Verfahren zur früherkennung von krebs |
| CN101495654A (zh) | 2006-04-19 | 2009-07-29 | 阿普里拉股份有限公司 | 无凝胶珠基测序的试剂、方法和文库 |
| CN103424541B (zh) | 2006-05-18 | 2018-01-30 | 分子压型学会股份有限公司 | 确定针对病状的个性化医疗介入的系统和方法 |
| US8768629B2 (en) * | 2009-02-11 | 2014-07-01 | Caris Mpi, Inc. | Molecular profiling of tumors |
| US20100184027A1 (en) | 2006-07-13 | 2010-07-22 | Epigenomics Ag | Methods and nucleic acids for analyses of cellular proliferative disorders |
| WO2008014458A2 (en) | 2006-07-27 | 2008-01-31 | Ludwig Institute For Cancer Research | Protein markers for the diagnosis and prognosis of ovarian and breast cancer |
| DK2089722T3 (en) | 2006-09-07 | 2018-01-22 | Otago Innovation Ltd | BIOMARKET FOR EARLY DETECTION OF ACUTE HEART DISORDERS |
| GB0700374D0 (en) | 2007-01-09 | 2007-02-14 | Oncomethylome Sciences S A | NDRG family methylation markers |
| US20080280768A1 (en) * | 2007-01-30 | 2008-11-13 | Oncotech, Inc. | Reagents and Methods for Predicting Drug Resistance |
| WO2008130516A1 (en) | 2007-04-11 | 2008-10-30 | Manel Esteller | Epigenetic biomarkers for early detection, therapeutic effectiveness, and relapse monitoring of cancer |
| US20100222230A1 (en) | 2007-04-11 | 2010-09-02 | The General Hospital Corporation | Diagnostic and prognostic methods for renal cell carcinoma |
| US8664358B2 (en) | 2007-06-29 | 2014-03-04 | Vermillion, Inc. | Predictive markers for ovarian cancer |
| CA2705952C (en) | 2007-11-23 | 2018-05-01 | British Columbia Cancer Agency Branch | Methods for detecting lung cancer and monitoring treatment response |
| EA018974B9 (ru) | 2008-02-05 | 2014-04-30 | Харбор Терапьютикс, Инк. | Твердые лекарственные формы |
| EP2245568A4 (en) * | 2008-02-20 | 2012-12-05 | Univ Mcmaster | EXPERIMENTAL SYSTEM FOR DETERMINING THE RESPONSE OF PATIENTS TO TREATMENT |
| US7745150B2 (en) | 2008-03-07 | 2010-06-29 | The University Of Connecticut | Methods for the detection and monitoring of congestive heart failure |
| EP2265642A4 (en) | 2008-03-12 | 2012-05-02 | Otago Innovation Ltd | BIOMARKERS |
| WO2009134420A2 (en) | 2008-05-01 | 2009-11-05 | The Salk Institute For Biological Studies | Epigenetic silencing of tumor suppressor genes |
| CN102084366A (zh) * | 2008-05-12 | 2011-06-01 | 皇家飞利浦电子股份有限公司 | 医学分析系统 |
| CN102232117A (zh) | 2008-10-14 | 2011-11-02 | 卡里斯Mpi公司 | 描绘肿瘤类型生物标志模式和特征集的基因靶和基因表达的蛋白靶 |
| EP2358912B1 (en) | 2008-10-30 | 2016-10-12 | Caris Life Sciences Switzerland Holdings GmbH | Methods for assessing rna patterns |
| GB2463401B (en) | 2008-11-12 | 2014-01-29 | Caris Life Sciences Luxembourg Holdings S A R L | Characterizing prostate disorders by analysis of microvesicles |
| WO2011109440A1 (en) | 2010-03-01 | 2011-09-09 | Caris Life Sciences Luxembourg Holdings | Biomarkers for theranostics |
| EP2202522A1 (en) | 2008-12-23 | 2010-06-30 | Universiteit Leiden | Methods for immobilizing microvesicles, means and methods for detecting them, and uses thereof |
| IL313131A (en) | 2009-02-11 | 2024-07-01 | Caris Mpi Inc | Molecular characterization of tumors |
| EP2421987A4 (en) | 2009-06-19 | 2012-10-31 | Wayne John Cancer Inst | USE OF THE METHYLATION STATUS OF MINT-LOCI AS MARKER FOR RECTAL CARCINOMAS |
| CA2779223A1 (en) | 2009-10-27 | 2011-05-12 | Caris Mpi, Inc. | Molecular profiling for personalized medicine |
| US8765713B2 (en) * | 2009-10-30 | 2014-07-01 | Keio University | Method for determination of sensitivity to anti-cancer agent |
| CA2782284A1 (en) | 2009-11-30 | 2011-06-03 | Caris Life Sciences Luxembourg Holdings, S.A.R.L. | Methods and systems for isolating, storing, and analyzing vesicles |
| US20140148348A1 (en) | 2010-01-13 | 2014-05-29 | Christine Kuslich | Dectection of gastrointestinal disorders |
| WO2011127219A1 (en) | 2010-04-06 | 2011-10-13 | Caris Life Sciences Luxembourg Holdings | Circulating biomarkers for disease |
| EP2564340B1 (en) * | 2010-04-29 | 2020-01-08 | The Regents of The University of California | Pathway recognition algorithm using data integration on genomic models (paradigm) |
| BR112013013656B1 (pt) | 2010-12-03 | 2021-01-26 | Kabushiki Kaisha Yakult Honsha | processo para determinação da sensibilidade de um indivíduo a um agente anticâncer, kit para realização do dito processo bem como processo de triagem para um agente de aperfeiçoamento de sensibilidade a um agente anticâncer |
| AU2011352167A1 (en) | 2010-12-28 | 2013-07-11 | Caris Mpi, Inc. | Molecular profiling for cancer |
| CN103403187A (zh) | 2011-01-18 | 2013-11-20 | 艾沃锐斯特基因有限公司 | 结肠直肠癌复发的预后特征 |
| US9797884B2 (en) * | 2011-03-24 | 2017-10-24 | Keio University | Marker for determination of sensitivity to anticancer agent |
| EP3825693A1 (en) * | 2011-04-29 | 2021-05-26 | Cancer Prevention And Cure, Ltd. | Methods of identification and diagnosis of lung diseases using classification systems and kits thereof |
| CA2838736A1 (en) | 2011-06-07 | 2012-12-13 | Caris Mpi, Inc. | Molecular profiling for cancer |
| GB201215944D0 (en) * | 2012-09-06 | 2012-10-24 | Univ Manchester | Image processing apparatus and method for fittng a deformable shape model to an image using random forests |
| EP2929350A4 (en) | 2012-12-04 | 2016-11-16 | Caris Mpi Inc | MOLECULAR PROFILING OF CANCER |
| US20140229544A1 (en) | 2013-02-12 | 2014-08-14 | BackPeddle, LLC | Sharing content in social networks |
| ITPD20130240A1 (it) | 2013-09-02 | 2015-03-03 | Optimae Srl | Metodo per la produzione di aste di occhiali in materiale composito a rigidità differenziata ed asta per occhiali ottenuta in accordo con tale metodo |
| EP2876167A1 (en) * | 2013-11-21 | 2015-05-27 | Institut Gustave Roussy | Microbiota composition, as a marker of responsiveness to chemotherapy, and use of microbial modulators (pre-,pro- or synbiotics) for improving the efficacy of a cancer treatment |
| FR3016461B1 (fr) | 2014-01-10 | 2017-06-23 | Imabiotech | Procede de traitement de donnees d'imagerie moleculaire et serveur de donnees correspondant |
| WO2015116868A2 (en) | 2014-01-29 | 2015-08-06 | Caris Mpi, Inc. | Molecular profiling of immune modulators |
| GB201405715D0 (en) | 2014-03-31 | 2014-05-14 | Abo Hamed Enass | Methods, apparatus and materials |
| EP3155758A4 (en) * | 2014-06-10 | 2018-04-11 | Sightline Innovation Inc. | System and method for network based application development and implementation |
| US10570457B2 (en) * | 2014-09-26 | 2020-02-25 | Medical Prognosis Institute A/S | Methods for predicting drug responsiveness |
| WO2016094330A2 (en) * | 2014-12-08 | 2016-06-16 | 20/20 Genesystems, Inc | Methods and machine learning systems for predicting the liklihood or risk of having cancer |
| WO2016141169A1 (en) | 2015-03-03 | 2016-09-09 | Caris Mpi, Inc. | Molecular profiling for cancer |
| CN106252749B (zh) | 2015-06-04 | 2020-12-29 | 松下知识产权经营株式会社 | 蓄电池包的控制方法以及蓄电池包 |
| IL258309B2 (en) | 2015-09-24 | 2023-03-01 | Caris Science Inc | Method, device and product of computer software for analyzing biological data |
| US20170132362A1 (en) * | 2015-11-09 | 2017-05-11 | Washington State University | Novel machine learning approach for the identification of genomic features associated with epigenetic control regions and transgenerational inheritance of epimutations |
| US20170175169A1 (en) * | 2015-12-18 | 2017-06-22 | Min Lee | Clinical decision support system utilizing deep neural networks for diagnosis of chronic diseases |
| US10065868B2 (en) | 2016-03-28 | 2018-09-04 | Saudi Arabian Oil Company | Coupling photovoltaic and concentrated solar power technologies for desalination |
| US11621057B2 (en) * | 2016-04-08 | 2023-04-04 | Biodesix, Inc. | Classifier generation methods and predictive test for ovarian cancer patient prognosis under platinum chemotherapy |
| AU2017278261A1 (en) | 2016-06-05 | 2019-01-31 | Berg Llc | Systems and methods for patient stratification and identification of potential biomarkers |
| US10328872B2 (en) | 2016-06-29 | 2019-06-25 | Hamilton Sundstrand Corporation | Methodology for simplification of aircraft harnessing in multi-redundant control systems |
| US10350280B2 (en) * | 2016-08-31 | 2019-07-16 | Medgenome Inc. | Methods to analyze genetic alterations in cancer to identify therapeutic peptide vaccines and kits therefore |
| MX2019002731A (es) | 2016-09-08 | 2019-10-02 | Curematch Inc | Optimizacion de opciones terapeuticas en medicina perzonalizada. |
| KR101936465B1 (ko) | 2016-09-21 | 2019-01-08 | 현대자동차주식회사 | 배터리 충전 시스템 및 방법 |
| US20180089373A1 (en) * | 2016-09-23 | 2018-03-29 | Driver, Inc. | Integrated systems and methods for automated processing and analysis of biological samples, clinical information processing and clinical trial matching |
| WO2018078142A1 (en) * | 2016-10-28 | 2018-05-03 | MAX-PLANCK-Gesellschaft zur Förderung der Wissenschaften e.V. | Means and methods for determining efficacy of fluorouracil (5-fu) in colorectal cancer (crc) therapy |
| AU2017258901A1 (en) * | 2016-12-30 | 2018-07-19 | Allarity Therapeutics Europe ApS | Methods for predicting drug responsiveness in cancer patients |
| WO2018146034A1 (en) | 2017-02-07 | 2018-08-16 | F. Hoffmann-La Roche Ag | Non-invasive test to predict response to therapy in colorectal cancer patients |
| WO2018146033A1 (en) | 2017-02-07 | 2018-08-16 | F. Hoffmann-La Roche Ag | Non-invasive test to predict recurrence of colorectal cancer |
| US11618926B2 (en) | 2017-02-28 | 2023-04-04 | Baylor Research Institute | Methods for diagnosing, prognosing, and treating colorectal cancer using biomarker expression |
| US20200024669A1 (en) * | 2017-03-20 | 2020-01-23 | Caris Mpi, Inc. | Genomic stability profiling |
| CN116148481A (zh) * | 2017-03-31 | 2023-05-23 | 学校法人庆应义塾 | 并用抗癌剂的感受性判定标记 |
| US11392827B1 (en) * | 2017-07-19 | 2022-07-19 | United States Of America As Represented By The Secretary Of The Navy | Deeper learning from the real-time transformative correction of and reasoning from neural network outputs |
| US10679129B2 (en) * | 2017-09-28 | 2020-06-09 | D5Ai Llc | Stochastic categorical autoencoder network |
| US11708600B2 (en) * | 2017-10-05 | 2023-07-25 | Decode Health, Inc. | Long non-coding RNA gene expression signatures in disease diagnosis |
| US20190317079A1 (en) * | 2017-10-16 | 2019-10-17 | Sightline Innovation Inc. | System and method for volatile organic compound detection |
| US11250345B1 (en) * | 2018-06-08 | 2022-02-15 | Intuit Inc. | Methods for identifying transactions with user location information |
| US11120364B1 (en) * | 2018-06-14 | 2021-09-14 | Amazon Technologies, Inc. | Artificial intelligence system with customizable training progress visualization and automated recommendations for rapid interactive development of machine learning models |
| US10423403B1 (en) | 2018-11-29 | 2019-09-24 | Capital One Services, Llc | Utilizing a machine learning model to predict metrics for an application development process |
| JP7462632B2 (ja) | 2018-11-30 | 2024-04-05 | カリス エムピーアイ インコーポレイテッド | 次世代分子プロファイリング |
| CA3140365A1 (en) | 2019-05-14 | 2020-11-19 | Tempus Labs, Inc. | Systems and methods for multi-label cancer classification |
| US10734096B1 (en) | 2019-11-29 | 2020-08-04 | Kpn Innovations, Llc | Methods and systems for optimizing supplement decisions |
| WO2021112918A1 (en) | 2019-12-02 | 2021-06-10 | Caris Mpi, Inc. | Pan-cancer platinum response predictor |
| AU2022249074A1 (en) * | 2021-03-31 | 2023-09-21 | PrognomIQ, Inc. | Multi-omic assessment |
-
2019
- 2019-12-02 JP JP2021530882A patent/JP7462632B2/ja active Active
- 2019-12-02 EP EP19888693.9A patent/EP3888021B1/en active Active
- 2019-12-02 MX MX2021006234A patent/MX2021006234A/es unknown
- 2019-12-02 EP EP24154019.4A patent/EP4369356A3/en active Pending
- 2019-12-02 WO PCT/US2019/064078 patent/WO2020113237A1/en not_active Ceased
- 2019-12-02 CA CA3121170A patent/CA3121170A1/en active Pending
- 2019-12-02 IL IL311084A patent/IL311084B1/en unknown
- 2019-12-02 IL IL283371A patent/IL283371B2/en unknown
- 2019-12-02 KR KR1020217020462A patent/KR20210111254A/ko active Pending
- 2019-12-02 AU AU2019389175A patent/AU2019389175B2/en active Active
-
2021
- 2021-05-28 US US17/334,483 patent/US11315673B2/en active Active
-
2022
- 2022-04-22 US US17/727,681 patent/US12165759B2/en active Active
-
2024
- 2024-03-26 JP JP2024049383A patent/JP7798947B2/ja active Active
- 2024-10-31 US US18/934,148 patent/US20250125034A1/en active Pending
-
2025
- 2025-03-05 AU AU2025201608A patent/AU2025201608A1/en active Pending
- 2025-12-25 JP JP2025281289A patent/JP2026048991A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JPWO2020113237A5 (https=) | ||
| JPWO2021112918A5 (https=) | ||
| Villegas et al. | Therapy response and prognosis of patients with early breast cancer with low positivity for hormone receptors–an analysis of 2765 patients from neoadjuvant clinical trials | |
| US20240331873A1 (en) | Variant based disease diagnostics and tracking | |
| JP2026048991A5 (https=) | ||
| Wei et al. | Intratumoral and intertumoral genomic heterogeneity of multifocal localized prostate cancer impacts molecular classifications and genomic prognosticators | |
| US20090275057A1 (en) | Diagnostic markers predictive of outcomes in colorectal cancer treatment and progression and methods of use thereof | |
| Tothill et al. | An expression-based site of origin diagnostic method designed for clinical application to cancer of unknown origin | |
| Buyse et al. | Biomarkers and surrogate end points—the challenge of statistical validation | |
| JP7634714B2 (ja) | 人工知能基盤の無細胞ＤＮＡの腫瘍由来変異の検出方法及びこれを用いたがんの早期診断方法｛Ｍｅｔｈｏｄ ｆｏｒ ｄｅｔｅｃｔｉｎｇ ｔｕｍｏｒ ｄｅｒｉｖｅｄ ｍｕｔａｔｉｏｎ ｆｒｏｍ ｃｅｌｌ－ｆｒｅｅ ＤＮＡ ｂａｓｅｄ ｏｎ ａｒｔｉｆｉｃｉａｌ ｉｎｔｅｌｌｉｇｅｎｃｅ ａｎｄ Ｍｅｔｈｏｄ ｆｏｒ ｅａｒｌｙ ｄｉａｇｎｏｓｉｓ ｏｆ ｃａｎｃｅｒ ｕｓｉｎｇ ｔｈｅ ｓａｍｅ｝ | |
| BR112014006432B1 (pt) | Método in vitro para diagnosticar se um indivíduo tem ou não câncer, método implementado por computador, produto de programa de computador | |
| JP2024149826A (ja) | 膵臓病変の評価における無細胞ｄｎａヒドロキシメチル化プロファイル | |
| D'angelica et al. | Folate receptor-α expression in resectable hepatic colorectal cancer metastases: patterns and significance | |
| West et al. | Molecular analysis-based treatment strategies for the management of non-small cell lung cancer | |
| Nicholson et al. | An update on the status of molecular testing for the indeterminate thyroid nodule and risk stratification of differentiated thyroid cancer | |
| Chen et al. | Prognostic impact of tumor spread through air spaces for T2aN0 stage IB non‐small cell lung cancer | |
| Goričar et al. | Clinical-pharmacogenetic models for personalized cancer treatment: application to malignant mesothelioma | |
| US20240347200A1 (en) | Systems and methods for early-stage cancer detection and subtyping | |
| CN102421920B (zh) | 用于肿瘤特征和标记物组鉴定,肿瘤分级的方法和用于癌的标记物组 | |
| KR102265529B1 (ko) | 복합 유전 정보 네트워크 분석에 기반한 질병 위험도 진단 방법 | |
| Bainer et al. | Gene expression in local stroma reflects breast tumor states and predicts patient outcome | |
| Mariani et al. | Integrated multidimensional analysis is required for accurate prognostic biomarkers in colorectal cancer | |
| Kim et al. | Identifying diagnostic MicroRNAs and investigating their biological implications in rectal cancer | |
| Werle et al. | A systems biology approach to define mechanisms, phenotypes, and drivers in PanNETs with a personalized perspective | |
| KR20120034778A (ko) | 티보자닙 반응 예측 |